Literature DB >> 25412239

Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence.

N Felici1, I Marcoccio2, R Giunta3, M Haerle4, C Leclercq5, G Pajardi6, S Wilbrand7, A V Georgescu8, G Pess9.   

Abstract

The aim of this study was to determine a definition of recurrence of Dupuytren disease that could be utilized for the comparison of the results independently from the treatment used. 24 hand surgeons from 17 countries met in an international consensus conference. The participants used the Delphi method to evaluate a series of statements: (1) the need for defining recurrence, (2) the concept of recurrence applied to the Tubiana staging system, (3) the concept of recurrence applied to each single treated joint, and (4) the concept of recurrence applied to the finger ray. For each item, the possible answer was given on a scale of 1-5: 1=maximum disagreement; 2=disagreement; 3=agreement; 4=strong agreement; 5=absolute agreement. There was consensus on disagreement if 1 and 2 comprised at least 66% of the recorded answers and consensus on agreement if 3, 4 and 5 comprised at least 66% of the recorded answers. If a threshold of 66% was not reached, the related statement was considered "not defined". A need for a definition of recurrence was established. The presence of nodules or cords without finger contracture was not considered an indication of recurrence. The Tubiana staging system was considered inappropriate for reporting recurrence. Recurrence was best determined by the measurement of a specific joint, rather than a total ray. Time 0 occurred between 6 weeks and 3 months. Recurrence was defined as a PED of more than 20° for at least one of treated joint, in the presence of a palpable cord, compared to the result obtained at time 0. This study determined the need for a standard definition of recurrence and reached consensus on that definition, which we should become the standard for the reporting of recurrence. If utilized in subsequent publications, this will allow surgeons to compare different techniques and make is easier to help patients make an informed choice. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25412239     DOI: 10.1055/s-0034-1394420

Source DB:  PubMed          Journal:  Handchir Mikrochir Plast Chir        ISSN: 0722-1819            Impact factor:   1.018


  8 in total

Review 1.  [Treatment of recurrent Dupuytren's disease].

Authors:  T Pillukat; L Walle; R Stüber; J Windolf; J van Schoonhoven
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

2.  Factors influencing recurrence and progression of Dupuytren's disease treated by Collagenase Clostridium histolitycum.

Authors:  Clarisa Simón-Pérez; Julian Alía-Ortega; Belen García-Medrano; Jose Ignacio Rodríguez-Mateos; Maria Brotat-Rodríguez; Hector Aguado-Hernandez; Miguel Angel Martín-Ferrero
Journal:  Int Orthop       Date:  2017-11-23       Impact factor: 3.075

3.  Skin Graft Review in Dermofasciectomy for Dupuytren's Contracture within 48 Hours: Challenging Historical Practice.

Authors:  Saif Akhter Ansari; James Andrew Kennedy; Fizan Younis
Journal:  J Hand Microsurg       Date:  2021-03-23

4.  Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: A prospective study.

Authors:  Rocco De Vitis; Marco Passiatore; Andrea Perna; Silvia Careri; Vitale Cilli; Giuseppe Taccardo
Journal:  J Orthop       Date:  2020-03-29

5.  Difference in Success Treating Proximal Interphalangeal and Metacarpophalangeal Joints with Collagenase: Results of 208 Treatments.

Authors:  Karina Liv Hansen; Jens Christian Werlinrud; Søren Larsen; Tune Ipsen; Jens Lauritsen
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-04-25

6.  Multiple Recurrences in Aggressive Forms of Dupuytren's Disease-Can Patients Benefit from Repeated Selective Fasciectomy?

Authors:  Sören Könneker; G Felix Broelsch; Nicco Krezdorn; Khaled Dastagir; Jörn W Kuhbier; Felix J Paprottka; Peter M Vogt
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-02-23

7.  Residual deformity versus recurrence following Dupuytren's palmar fasciectomy-a long term follow-up of 142 cases.

Authors:  Niranj Ganeshan Radhamony; Rajiv Ramachandran Nair; Sachith Sreenivasan; Sriganesh Walkay; Aditya Soni; Rahul Kakkar
Journal:  Ann Med Surg (Lond)       Date:  2022-01-01

8.  A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren's Disease.

Authors:  Sophie A Riesmeijer; Oliver W G Manley; Michael Ng; Ilja M Nolte; Dieuwke C Broekstra; Paul M N Werker; Dominic Furniss
Journal:  Plast Reconstr Surg       Date:  2019-02       Impact factor: 4.730

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.